FDA considers adding a dozen peptides to its bulk drug compounding list RAPS The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and BPC 157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven San Diego Orthobiologics Medical Group FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC BPC 157 and Erectile Dysfunction: What the Evidence Actually Shows